Market Overview

Piper Jaffray Reiterates Neutral Rating, $109 PT on MWI Veterinary Supply

Related MWIV
Top 4 NASDAQ Stocks In The Medical Equipment Wholesale Industry With The Highest ROA
Top 4 Stocks In The Medical Equipment Wholesale Industry With The Highest Revenue

In a report published Wednesday, Piper Jaffray & Co. reiterated its Neutral rating and $109.00 price target on MWI Veterinary Supply (NASDAQ: MWIV).

Piper Jaffray noted, “MWIV acquired Prescription Containers, Inc., otherwise known as PCI Animal Health, a distributor of companion animal health products to over 2,000 veterinary practices primarily in the Northeastern part of the U.S. MWIV paid $17 MM or 0.5x PCI's CY12 revenues of ~$33 MM. While the acquisition is expected to be slightly accretive to FY13 earnings, we believe the acquisition is a positive for the following reasons: 1) it is a good strategic fit for MWIV as PCI expands the company's presence in the Northeast/East Coast and 2) it brings the addition of about 800 new vet customers. Despite this favorable development, we maintain our Neutral rating and $109 PT primarily due to valuation.”

MWI Veterinary Supply closed on Monday at $110.00.

Latest Ratings for MWIV

DateFirmActionFromTo
Nov 2014UBSDowngradesBuyNeutral
May 2014UBSInitiates Coverage onBuy
Feb 2014Piper JaffrayUpgradesNeutralOverweight

View More Analyst Ratings for MWIV
View the Latest Analyst Ratings

Posted-In: Piper Jaffray & Co.Analyst Color Reiteration Analyst Ratings

 

Related Articles (MWIV)

Around the Web, We're Loving...

Get Benzinga's Newsletters